NHI Files 8-K on Shareholder Vote Matters

TL;DR

NHI filed an 8-K on shareholder votes, check it for governance updates.

AI Summary

National Health Investors Inc. (NHI) filed an 8-K on May 29, 2024, reporting on matters submitted to a vote of security holders. The earliest reported date for these matters was May 22, 2024. The filing details the company's corporate structure and addresses related to its principal executive offices in Murfreesboro, TN.

Why It Matters

This filing informs investors about significant corporate actions and votes, providing transparency on governance and shareholder decisions.

Risk Assessment

Risk Level: low — This is a routine filing reporting on matters submitted to a vote of security holders, not indicating any immediate financial distress or significant operational change.

Key Numbers

• 001-10822 — SEC File Number (Identifies the company's filing history with the SEC.)
• 62-1470956 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• NATIONAL HEALTH INVESTORS INC (company) — Registrant
• May 29, 2024 (date) — Date of Report
• May 22, 2024 (date) — Date of Earliest Reported
• Murfreesboro, TN (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value NHI New York Stock Exchange

Filing Documents

• nhi-20240529.htm (8-K) — 35KB
• 0000877860-24-000054.txt ( ) — 161KB
• nhi-20240529.xsd (EX-101.SCH) — 2KB
• nhi-20240529_lab.xml (EX-101.LAB) — 23KB
• nhi-20240529_pre.xml (EX-101.PRE) — 13KB
• nhi-20240529_htm.xml (XML) — 3KB

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. (1) The Company's annual meeting of stockholders was held on May 22, 2024 at The View at Fountains, 1500 Medical Center Parkway, Suite 1D, Murfreesboro, Tennessee 37129. As of the record date, there were a total of 43,424,841 shares of Common Stock outstanding and entitled to vote at the annual meeting. At the annual meeting, 37,006,346 shares of Common Stock were represented in person or by proxy; therefore, a quorum was present. (2) Set forth below are the matters acted upon by the Company's stockholders at the annual meeting and the final voting results on each such matter. (1) The nominees named below were elected to serve as members of the Board of Directors of the Company for a three-year term until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified, and the voting results were as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes D. Eric Mendelsohn 30,820,578 280,067 946,910 4,958,791 Charlotte A. Swafford 20,745,812 10,365,642 936,101 4,958,791 Robert T. Webb 19,211,271 11,890,320 945,964 4,958,791 (2) The compensation paid to NHI's named executive officers was approved with the following voting results: Votes For Votes Against Abstentions Broker Non-Votes 29,685,288 1,338,532 1,023,735 4,958,791 (3) The selection of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, and the voting results were as follows: Votes For Votes Against Abstentions 36,477,341 480,667 48,338 Additionally, Tracy M. J. Colden was appointed as the Chair of the Nominating and Corporate Governance Committee effective May 22, 2024, replacing James R. Jobe, who remains a member of the committee.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. National Health Investors, Inc. By: /s/ John L. Spaid Name: John L. Spaid Title: Chief Financial Officer Date: May 29, 2024

View Full Filing

View this 8-K filing on SEC EDGAR